Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD
Public ClinicalTrials.gov record NCT05181995. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 50 mg NYX-783 Once Daily Compared to Placebo in Participants With Post-Traumatic Stress Disorder (PTSD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 50 mg NYX-783 Once Daily Compared to Placebo in Participants with Post-Traumatic Stress Disorder (PTSD)
Study identification
- NCT ID
- NCT05181995
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 121 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2021
- Primary completion
- Mar 29, 2023
- Completion
- Mar 29, 2023
- Last update posted
- Apr 6, 2023
2021 – 2023
United States locations
- U.S. sites
- 37
- U.S. states
- 15
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aptinyx Clinical Site | Tuscaloosa | Alabama | 35404 | — |
| Aptinyx Clinical Site | Phoenix | Arizona | 85012 | — |
| Aptinyx Clinical Site | Bentonville | Arkansas | 72712 | — |
| Aptinyx Clinical Site | Bellflower | California | 90706 | — |
| Aptinyx Clinical Site | Glendale | California | 91206 | — |
| Aptinyx Clinical Site | La Jolla | California | 92037 | — |
| Aptinyx Clinical Site | Oceanside | California | 92056 | — |
| Aptinyx Clinical Site | Riverside | California | 92506 | — |
| Aptinyx Clinical Site | Santa Ana | California | 92705 | — |
| Aptinyx Clinical Site | Temecula | California | 92591 | — |
| Aptinyx Clinical Site | Torrance | California | 90502 | — |
| Aptinyx Clinical Site | Colorado Springs | Colorado | 80910 | — |
| Aptinyx Clinical Site | Denver | Colorado | 80209 | — |
| Aptinyx Clinical Site | Hialeah | Florida | 33012 | — |
| Aptinyx Clinical Site | Hollywood | Florida | 33020 | — |
| Aptinyx Clinical Site | Jacksonville | Florida | 32256 | — |
| Aptinyx Clinical Site | Jupiter | Florida | 33458 | — |
| Aptinyx Clinical Site | Miami | Florida | 33125 | — |
| Aptinyx Clinical Site | Miami | Florida | 33174 | — |
| Aptinyx Clinical Site | Miami Lakes | Florida | 33014 | — |
| Aptinyx Clinical Site | Okeechobee | Florida | 34972 | — |
| Aptinyx Clinical Site | Orlando | Florida | 32801 | — |
| Aptinyx Clinical Site | Atlanta | Georgia | 30331 | — |
| Aptinyx Clinical Site | Boston | Massachusetts | 02131 | — |
| Aptinyx Clinical Site | Las Vegas | Nevada | 89102 | — |
| Aptinyx Clinical Site | Albuquerque | New Mexico | 87102 | — |
| Aptinyx Clinical Site | New York | New York | 10036 | — |
| Aptinyx Clinical Site | Cincinnati | Ohio | 45219 | — |
| Aptinyx Clinical Site | Dayton | Ohio | 45432 | — |
| Aptinyx Clinical Site | Kettering | Ohio | 45439 | — |
| Aptinyx Clinical Site | North Canton | Ohio | 44720 | — |
| Aptinyx Clinical Site | Media | Pennsylvania | 19063 | — |
| Aptinyx Clinical Site | Memphis | Tennessee | 38119 | — |
| Aptinyx Clinical Site | Austin | Texas | 78737 | — |
| Aptinyx Clinical Site | Fort Worth | Texas | 76104 | — |
| Aptinyx Clinical Site | Houston | Texas | 77090 | — |
| Aptinyx Clinical Site | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05181995, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2023 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05181995 live on ClinicalTrials.gov.